Maackiain suppresses the development of cervical cancer via AMPK priming autophagy
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgad100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Juan He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, First Affiliated Hospital, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Anhui Science and Technology Department, Anhui Education Department, Anhui University of Chinese Medicine.
Abstract (Originalsprache)
Background
Maackiain (Mac), a flavonoid analog isolated from Sophora flavescens, exhibits neuroprotective, anti-allergic, anti-inflammatory, and pro-apoptotic effects. It is not clear whether Mac has a therapeutic effect on cervical cancer.
Method
In this work, we used RT-qPCR, western blot, immunofluorescence, and related methods to detect the therapeutic mechanism of Mac for cervical cancer.
Results
We demonstrated that Mac significantly inhibited the proliferation, migration, and invasion of human cervical cancer cell lines HeLa and SiHa. And, Mac enhanced the pro-apoptotic effects of cisplatin in treating cervical cancer cells. Mac has shown good efficacy in treating cervical cancer. Furthermore, Mac inhibited the mammalian target of the rapamycin (mTOR) pathway, thereby inducing autophagy in cervical cancer cells. The regulation of mTOR/autophagy pathway by Mac relied on the activation of AMP-activated protein kinase (AMPK), and the inhibition of the AMPK reversed the Mac’s anti-cervical cancer activity. In addition, experimental study of Mac in mouse xenograft tumor model further confirmed its good anti-cervical cancer activity.
Conclusion
Mac inhibits human cervical cancer by activating the AMPK/mTOR/autophagy pathway, indicating that it is a potential natural compound for the treatment of cervical cancer. This study also provides a feasible molecular mechanism for the treatment of cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, First Affiliated Hospital, Anhui Medical University, Hefei, China.
- Department of Gynecology, Anhui Maternal and Child Health Hospital, Hefei, China.
- Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
ORCID-Profile: Chenggui Miao
Förderung
- Anhui Science and Technology Department
- Anhui Education Department
- Anhui University of Chinese Medicine
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province
- Anhui Administration of Traditional Chinese Medicine
Zitieren
APA
He, J., Xiang, L., Zhu, T., Wang, H., Huang, Y., Li, H., Miao, C., Zhuang, Y., & Cao, Y. (2024). Maackiain suppresses the development of cervical cancer via AMPK priming autophagy. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad100
Vancouver
He J, Xiang L, Zhu T, Wang H, Huang Y, Li H, et al. Maackiain suppresses the development of cervical cancer via AMPK priming autophagy. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgad100
BibTeX
@article{He2024,
author = {He, Juan and Xiang, Lan and Zhu, Tingting and Wang, Haiyan and Huang, Yurong and Li, Hui and Miao, Chenggui and Zhuang, Yali and Cao, Yunxia},
title = {Maackiain suppresses the development of cervical cancer via AMPK priming autophagy},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgad100}
}
EUVIMED